Pharmaceutical companies with the most ‘New Chemical Entity’ drugs

Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs. This is one of the longest exclusivity terms provided by…
The post Pharmaceutical companies with the most ‘New Chemic…


New patent for Sunovion Resp drug LONHALA MAGNAIR KIT

Annual Drug Patent Expirations for LONHALA+MAGNAIR+KIT Lonhala Magnair Kit is a drug marketed by Sunovion Resp and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Sunovion Resp drug LONHALA MAGNAIR KIT app…


Biotechblog